Panagora Asset Management Inc Applied Genetic Technologies Corp Transaction History

Panagora Asset Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$3.94 - $8.19 $1,761 - $3,660	-447 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$4.38 - $6.43 $2,860 - $4,198	-653 Reduced 59.36%	447 $2,000
Q4 2019 Feb 12, 2020	SELL	$2.69 - $4.92 $23,534 - $43,045	-8,749 Reduced 88.83%	1,100 $5,000
Q3 2019 Nov 12, 2019	SELL	$2.59 - $4.16 $2,882 - $4,630	-1,113 Reduced 10.15%	9,849 $41,000
Q2 2019 Aug 09, 2019	SELL	$3.6 - $4.78 $860 - $1,142	-239 Reduced 2.13%	10,962 $42,000
Q1 2019 May 15, 2019	SELL	$2.62 - $4.44 $171,937 - $291,375	-65,625 Reduced 85.42%	11,201 $47,000
Q4 2018 Feb 14, 2019	BUY	$2.28 - $7.15 $156,879 - $491,970	68,807 Added 858.05%	76,826 $191,000
Q3 2018 Nov 13, 2018	SELL	$3.85 - $7.35 $121,348 - $231,664	-31,519 Reduced 79.72%	8,019 $59,000
Q2 2018 Aug 14, 2018	SELL	$3.7 - $5.65 $158,382 - $241,853	-42,806 Reduced 51.98%	39,538 $146,000
Q1 2018 May 15, 2018	BUY	$3.65 - $5.2 $47,267 - $67,340	12,950 Added 18.66%	82,344 $317,000
Q4 2017 Feb 14, 2018	BUY	$3.4 - $4.15 $67,840 - $82,804	19,953 Added 40.36%	69,394 $250,000
Q3 2017 Nov 14, 2017	BUY	$3.55 - $5.25 $175,515 - $259,565	49,441	49,441 $195,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.